OUABAIN INHIBITS ENDOTHELIUM-DEPENDENT RELAXATIONS TO ARACHIDONIC-ACID IN CANINE CORONARY-ARTERIES
- 1 January 1985
- journal article
- research article
- Vol. 235 (1) , 81-86
Abstract
Experiments were designed to analyze the effects of ouabain on the actions of exogenous arachidonic acid on endothelial and vascular smooth muscle cells. Rings or strips were prepared from left circumflex canine coronary arteries and suspended for isometric tension recording in organ chambers filled with oxygenated modified Krebs-Ringer-bicarbonate solution. During contractions evoked by prostaglandin F2.alpha., arachidonic acid caused relaxations both in the presense and the absence of endothelium. However, removal of the endothelium reduced its inhibitory action. Indomethacin prevented the relaxations in rings without endothelium, but did not affect the response to high doses (10-6 to 10-5 M) of arachidonic acid in preparations with endothelium. The inhibitor of lipoxygenase, nordihydroguaiaretic acid, had no effect on the inhibitory responses to arachidonic acid in rings with or without endothelium. Ouabain abolished both the endothelium-dependent and the direct relaxations to arachidonic acid. Endothelium-dependent relaxations in response to oleic acid, elaidic acid, adenosine diphosphate and thrombin were not affected by ouabain. In the presence of indomethacin, coronary artery strips without endothelium were relaxed by arachidonic acid only when layered (intimal surface against intimal surface) with a longitudinal strip with endothelium. In layered preparations, treatment of the intact longitudinal strip with ouabain before layering prevented the relaxation, whereas pretreatment of the strip without endothelium had no effect. These experiments demonstrate that: (1) arachidonic acid stimulates the release of a relaxing factor from the endothelial cells of canine coronary arteries which differs from prostaglandins; (2) ouabain prevents this effect by acting on endothelial cells; and (3) the selective effect of ouabain on endothelium-dependent relaxations induced by arachidonic acid indicates that it either stimulates the release of a factor different from that produced by other endothelium-dependent relaxing substances and/or causes the release of the same relaxing mediator by different means.This publication has 14 references indexed in Scilit:
- Spironolactone- and Canrenone-Induced Changes in Hepatic (Na+, K+)ATPase Activity, Surface Membrane Cholesterol and Phospholipid, and Fluorescence Polarization in the Rat†Hepatology, 1983
- Modulation of cardiac glycoside inhibition of (Na+ + K+)-ATPase by membrane lipids. Difference between speciesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Modulation by S–Adenosyl–L–Methionine of Hepatic Na+, K+–Atpase, Membrane Fluidity, and Bile Flow in Rats With Ethinyl Estradiol–Induced CholestasisHepatology, 1983
- A comparison of antigen-induced and calcium ionophore A23187 induced contraction of isolated guinea pig tracheaCanadian Journal of Physiology and Pharmacology, 1981
- Prostacyclin (PGI2) mediates hypoxic relaxation of bovine coronary arterial stripsProstaglandins, 1981
- RELAXATION OF VASCULAR SMOOTH-MUSCLE BY ISOPROTERENOL, DIBUTYRYL-CYCLIC AMP AND THEOPHYLLINE1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Parallel inhibition of neutrophil arachidonic acid metabolism and lysosomal enzyme secretion by nordihydroguaiaretic acidLife Sciences, 1980
- Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endotheliumThrombosis Research, 1977
- Coronary Tone Modulation: Formation and Actions of Prostaglandins, Endoperoxides, and ThromboxanesScience, 1977